The production of interferon-γ-inducible protein 10 by granulocytes and monocytes is associated with ulcerative colitis disease activity

Journal of Gastroenterology

Volumn 42, Issue 12, 2007, Pages 947-956

  Noguchi, Atsushi ^a   Watanabe, Kenji ^a   Narumi, Shosaku ^b   Yamagami, Hirokazu ^a   Fujiwara, Yasuhiro ^a   Higuchi, Kazuhide ^a   Oshitani, Nobuhide ^a   Arakawa, Tetsuo ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Stelic Institute of Regenerative Medicine   (Japan)

Author keywords

Adsorptive apheresis; Granulocyte; IP 10; Monocyte; Ulcerative colitis

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; PREDNISOLONE; SALAZOSULFAPYRIDINE; STEROID;

ADULT; AGED; APHERESIS; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COLON BIOPSY; COLON SURGERY; COLONOSCOPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DRUG DOSE REDUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUSHING; GRANULOCYTE; HEADACHE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MONOCYTE; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADULT; AGED; BIOPSY; BLOOD COMPONENT REMOVAL; CHEMOKINE CXCL10; COLITIS, ULCERATIVE; COLONOSCOPY; FEMALE; GRANULOCYTES; HUMANS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; MONOCYTES;

EID: 37549016755     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-007-2118-9     Document Type: Article

References (52)

1. DK Podolsky 2002 Inflammatory bowel disease N Engl J Med 347:417-29 12167685 10.1056/NEJMra020831 1:CAS:528:DC%2BD38XlvFKrt7s%3D
2. F Shanahan 2001 Inflammatory bowel disease: Immunodiagnostics, immunotherapeutics, and ecotherapeutics Gastroenterology 120:622-35 11179240 10.1053/gast.2001.22122 1:CAS:528:DC%2BD3MXhvFKntrY%3D
3. SB Hanauer 2006 Inflammatory bowel disease: Epidemiology, pathogenesis, and therapeutic opportunities Inflamm Bowel Dis 12(Suppl 1):S3-9 16378007 10.1097/01.MIB.0000195385.19268.68
4. RP MacDermott IR Sanderson HC Reinecker 1998 The central role of chemokines (chemotactic cytokines) in the immunopathogenesis of ulcerative colitis and Crohn's disease Inflamm Bowel Dis 4:54-67 9552229 1:STN:280:DyaK1c7nslKmtg%3D%3D
5. AD Luster 1998 Chemokines - chemotactic cytokines that mediate inflammation N Engl J Med 338:436-45 9459648 10.1056/NEJM199802123380706 1:CAS:528:DyaK1cXht1Wrsrc%3D
6. MB Dwinell N Lugering L Eckmann MF Kagnoff 2001 Regulated production of interferon-inducible T-cell chemoattractants by human intestinal epithelial cells Gastroenterology 120:49-59 11208713 10.1053/ gast.2001.20914 1:CAS:528:DC%2BD3MXoslCqsg%3D%3D
7. WW Agace AI Roberts L Wu C Greineder EC Ebert CM Parker 2000 Human intestinal lamina propria and intraepithelial lymphocytes express receptors specific for chemokines induced by inflammation Eur J Immunol 30:819-26 10741397 10.1002/ 1521-4141(200003)30:3<819::AID-IMMU819>3.0.CO;2-Y 1:CAS:528:DC%2BD3cXhvVChuro%3D
8. JM Farber 1997 Mig and IP-10: CXC chemokines that target lymphocytes J Leukoc Biol 61:246-57 9060447 1:CAS:528:DyaK2sXitVaisbc%3D
9. S Gasperini M Marchi F Calzetti C Laudanna L Vicentini H Olsen 1999 Gene expression and production of the monokine induced by IFN-gamma (MIG), IFN-inducible T cell alpha chemoattractant (I-TAC), and IFN-gamma-inducible protein-10 (IP-10) chemokines by human neutrophils J Immunol 162:4928-37 10202039 1:CAS:528:DyaK1MXisFOlsLk%3D
10. NH Hamilton JL Banyer AJ Hapel S Mahalingam AJ Ramsay IA Ramshaw 2002 IFN-gamma regulates murine interferon-inducible T cell alpha chemokine (I-TAC) expression in dendritic cell lines and during experimental autoimmune encephalomyelitis (EAE) Scand J Immunol 55 171-7 11896933 1:CAS:528:DC%2BD38XhvF2ktbs%3D
11. G Kolios KL Wright NJ Jordan JB Leithead DA Robertson J Westwick 1999 C-X-C and C-C chemokine expression and secretion by the human colonic epithelial cell line, HT-29: Differential effect of T lymphocyte-derived cytokines Eur J Immunol 29:530-6 10064068 10.1002/ (SICI)1521-4141(199902)29:02<530::AID-IMMU530>3.0.CO;2-Y 1:CAS:528:DyaK1MXhsVamsrw%3D
12. A Sauty M Dziejman RA Taha AS Iarossi K Neote EA Garcia-Zepeda 1999 The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells J Immunol 162:3549-58 10092813 1:CAS:528:DyaK1MXhvV2qsr0%3D
13. S Narumi Y Tominaga M Tamaru S Shimai H Okumura K Nishioji 1997 Expression of IFN-inducible protein-10 in chronic hepatitis J Immunol 158:5536-44 9164978 1:CAS:528:DyaK2sXjtl2qsbo%3D
14. A Shimada J Morimoto K Kodama R Suzuki Y Oikawa O Funae 2001 Elevated serum IP-10 levels observed in type 1 diabetes Diabetes Care 24:510-5 11289477 10.2337/diacare.24.3.510 1:CAS:528:DC%2BD3MXit1erurs%3D
15. TL Sorensen M Tani J Jensen V Pierce V Pierce C Lucchinetti 1999 Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients J Clin Invest 103:807-15 10079101 1:CAS:528:DyaK1MXhvFaku7g%3D
16. M Uguccioni P Gionchetti DF Robbiani F Rizzello S Peruzzo M Campieri 1999 Increased expression of IP-10, IL-8, MCP-1, and MCP-3 in ulcerative colitis Am J Pathol 155:331-6 10433925 1:CAS:528:DyaK1MXls1Whsrc%3D
17. U Helwig P Gionchetti F Rizzello K Lammers T Kuhbacher S Schreiber 2004 CXC and CC chemokine expression in inflamed and noninflamed pelvic ileal pouch tissue Int J Colorectal Dis 19:165-70 12827410 10.1007/ s00384-003-0500-5
18. F Autschbach T Giese N Gassler B Sido G Heuschen U Heuschen 2002 Cytokine/chemokine messenger-RNA expression profiles in ulcerative colitis and Crohn's disease Virchows Arch 441:500-13 12447682 10.1007/ s00428-002-0684-z 1:CAS:528:DC%2BD3sXos1eltA%3D%3D
19. S Sasaki H Yoneyama K Suzuki H Suriki T Aiba S Watanabe 2002 Blockade of CXCL10 protects mice from acute colitis and enhances crypt cell survival Eur J Immunol 32:3197-205 12555665 10.1002/ 1521-4141(200211)32:11<3197::AID-IMMU3197>3.0.CO;2-1 1:CAS:528:DC%2BD38XovF2qs7w%3D
20. T Shimoyama K Sawada N Hiwatashi T Sawada K Matsueda A Munakata 2001 Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: A multicenter study J Clin Apher 16:1-9 11309823 10.1002/jca.1000 1:STN:280:DC%2BD3M3hvFaitg%3D%3D
21. H Hanai F Watanabe K Takeuchi T Iida M Yamada Y Iwaoka 2003 Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: A prospective, uncontrolled, pilot study Clin Gastroenterol Hepatol 1:28-35 15017514 10.1053/jcgh.2003.50005
22. Y Suzuki N Yoshimura AR Saniabadi Y Saito 2004 Selective granulocyte and monocyte adsorptive apheresis as a first-line treatment for steroid naive patients with active ulcerative colitis: A prospective uncontrolled study Dig Dis Sci 49:565-71 15185858 10.1023/ B:DDAS.0000026299.43792.ae 1:CAS:528:DC%2BD2cXjs1WqurY%3D
23. M Naganuma S Funakoshi A Sakuraba H Takagi N Inoue H Ogata 2004 Granulocytapheresis is useful as an alternative therapy in patients with steroid-refractory or -dependent ulcerative colitis Inflamm Bowel Dis 10:251-7 15290920 10.1097/00054725-200405000-00012
24. H Hanai F Watanabe M Yamada Y Sato K Takeuchi T Iida 2004 Adsorptive granulocyte and monocyte apheresis versus prednisolone in patients with corticosteroid-dependent moderately severe ulcerative colitis Digestion 70 36-44 15297776 10.1159/000080079 1:CAS:528:DC%2BD2cXntFSgtr8%3D
25. T Yamamoto S Umegae T Kitagawa Y Yasuda Y Yamada D Takahashi 2004 Granulocyte and monocyte adsorptive apheresis in the treatment of active distal ulcerative colitis: A prospective, pilot study Aliment Pharmacol Ther 20:783-92 15379839 10.1111/j.1365-2036.2004.02189.x 1:STN:280:DC%2BD2cvmvFSjtQ%3D%3D
26. E Domenech J Hinojosa M Esteve-Comas F Gomollon JM Herrera G Bastida 2004 Granulocyteaphaeresis in steroid-dependent inflammatory bowel disease: A prospective, open, pilot study Aliment Pharmacol Ther 20:1347-52 15606397 10.1111/j.1365-2036.2004.02288.x 1:STN:280:DC%2BD2cnjtVyrsw%3D%3D
27. B Giampaolo P Giuseppe B Michele M Alessandro S Fabrizio C Alfonso 2006 Treatment of active steroid-refractory inflammatory bowel diseases with granulocytapheresis: Our experience with a prospective study World J Gastroenterol 12:2201-4 16610021
28. T Tomomasa A Kobayashi H Kaneko S Mika S Maisawa Y Chino 2003 Granulocyte adsorptive apheresis for pediatric patients with ulcerative colitis Dig Dis Sci 48;750-4 12741466 10.1023/A:1022892927121
29. AA Pineda 2006 Developments in the apheresis procedure for the treatment of inflammatory bowel disease Inflamm Bowel Dis 12 Suppl 1:S10-4 16378005 10.1097/01.MIB.0000195386.19268.b3
30. WJ Sandborn 2006 Preliminary data on the use of apheresis in inflammatory bowel disease Inflamm Bowel Dis 12(Suppl 1):S15-21 16378006 10.1097/01.MIB.0000195387.26892.22
31. AR Saniabadi H Hanai K Takeuchi K Umemura M Nakashima T Adachi 2003 Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes Ther Apher Dial 7:48-59 12921115 10.1046/j.1526-0968.2003.00012.x
32. M Ohara AR Saniabadi S Kokuma I Hirata M Adachi T Agishi 1997 Granulocytapheresis in the treatment of patients with rheumatoid arthritis Artif Organs 21:989-94 9288869 1:STN:280:ByiH3szitVQ%3D
33. AR Saniabadi H Hanai Y Suzuki T Ohmori K Sawada N Yoshimura 2005 Adacolumn for selective leukocytapheresis as a non-pharmacological treatment for patients with disorders of the immune system: An adjunct or an alternative to drug therapy? J Clin Apher 20:171-84 15892107 10.1002/jca.20046
34. N Kashiwagi K Sugimura H Koiwai H Yamamoto T Yoshikawa AR Saniabadi 2002 Immunomodulatory effects of granulocyte and monocyte adsorption apheresis as a treatment for patients with ulcerative colitis Dig Dis Sci 47:1334-41 12064810 10.1023/A:1015330816364 1:CAS:528:DC%2BD38XltFakurw%3D
35. W Ramlow J Emmrich P Ahrenholz G Sparmann N Kashiwagi M Franz 2005 In vitro and in vivo evaluation of Adacolumn cytapheresis in healthy subjects J Clin Apher 20:72-80 15892085 10.1002/jca.20053
36. N Kashiwagi I Hirata R Kasukawa 1998 A role for granulocyte and monocyte apheresis in the treatment of rheumatoid arthritis Ther Apher 2:134-41 10225715 10.1111/j.1744-9987.1998.tb00091.x 1:CAS:528:DyaK1cXjslGgurc%3D
37. H Hanai F Watanabe AR Saniabadi I Matsushitai K Takeuchi T Iida 2002 Therapeutic efficacy of granulocyte and monocyte adsorption apheresis in severe active ulcerative colitis Dig Dis Sci 47:2349-53 12395908 10.1023/ A:1020159932758
38. H Hanai T Iida M Yamada Y Sato K Takeuchi T Tanaka 2006 Effects of Adacolumn selective leukocytapheresis on plasma cytokines during active disease in patients with active ulcerative colitis World J Gastroenterol 12:3393-9 16733857 1:CAS:528:DC%2BD28XnsFWktb8%3D
39. A Andoh T Tsujikawa O Inatomi Y Deguchi M Sasaki H Obata 2005 Leukocytapheresis therapy modulates circulating T cell subsets in patients with ulcerative colitis Ther Apher Dial 9:270-6 15967005 10.1111/j.1774-9987.2005.00270.x 1:CAS:528:DC%2BD2MXps1Kht7o%3D
40. Y Tsukada T Nakamura M Iimura BE Iizuka N Hayashi 2002 Cytokine profile in colonic mucosa of ulcerative colitis correlates with disease activity and response to granulocytapheresis Am J Gastroenterol 97:2820-8 12425554 10.1111/j.1572-0241.2002.07029.x 1:CAS:528:DC%2BD38XptFaks7w%3D
41. KW Schroeder WJ Tremaine DM Ilstrup 1987 Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study N Engl J Med 317:1625-9 3317057 1:STN:280:BieD28rnsl0%3D
42. S Majumder LZ Zhou P Chaturvedi G Babcock S Aras RM Ransohoff 1998 p48/ STAT-1 alpha-containing complexes play a predominant role in induction of IFN-gamma-inducible protein, 10 kDa (IP-10) by IFN-gamma alone or in synergy with TNF-alpha J Immunol 161:4736-44 9794404 1:CAS:528:DyaK1cXntVWgsLk%3D
43. AJ Swaak HG van den Brink LA Aarden 1996 Cytokine production (IL-6 and TNF alpha) in whole blood cell cultures of patients with systemic lupus erythematosus Scand J Rheumatol 25 233-8 8792800 10.3109/ 03009749609069992 1:STN:280:BymA1cvpsVQ%3D
44. KM Kopydlowski CA Salkowski MJ Cody N van Rooijen J Major TA Hamilton 1999 Regulation of macrophage chemokine expression by lipopolysaccharidesss in vitro and in vivo J Immunol 163:1537-44 10415057 1:CAS:528:DyaK1MXkslOgsLs%3D
45. T Kawai O Takeuchi T Fujita J Inoue PF Muhlradt S Sato 2001 Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes J Immunol 167:5887-94 11698465 1:CAS:528:DC%2BD3MXotlamurc%3D
46. O Inatomi A Andoh K Kitamura H Yasui Z Zhang Y Fujiyama 2005 Butyrate blocks interferon-gamma-inducible protein-10 release in human intestinal subepithelial myofibroblasts J Gastroenterol 40:483-9 15942713 10.1007/ s00535-005-1573-4 1:CAS:528:DC%2BD2MXlslGmsbs%3D
47. KA Papadakis J Prehn D Zhu C Landers J Gaiennie PR Fleshner 2004 Expression and regulation of the chemokine receptor CXCR3 on lymphocytes from normal and inflammatory bowel disease mucosa Inflamm Bowel Dis 10:778-88 15626897 10.1097/00054725-200411000-00013
48. YH Yuan T ten Hove FO The JF Slors SJ van Deventer AA te Velde 2001 Chemokine receptor CXCR3 expression in inflammatory bowel disease Inflamm Bowel Dis 7:281-6 11720316 10.1097/00054725-200111000-00001 1:STN:280:DC%2BD3MnnsVeltg%3D%3D
49. P Biswas B Mantelli H Hasson A Vecchi A Saniabadi A Lazzarin 2003 In vivo modulation of leukocyte trafficking receptor following therapeutic purging of myeloid cells: Implications for treatment of HIV infection and other immune disorders Clin Immunol 109:355-8 14697751 10.1016/ j.clim.2003.07.001 1:CAS:528:DC%2BD3sXhtVSju7rF
50. P Rutgeerts WJ Sandborn BG Feagan W Reinisch A Olson J Johanns 2005 Infliximab for induction and maintenance therapy for ulcerative colitis N Engl J Med 353:2462-76 16339095 10.1056/NEJMoa050516 1:CAS:528:DC%2BD2MXhtlShurjE
51. Y Sawa N Oshitani K Adachi K Higuchi T Matsumoto T Arakawa 2003 Comprehensive analysis of intestinal cytokine messenger RNA profile by real-time quantitative polymerase chain reaction in patients with inflammatory bowel disease Int J Mol Med 11:175-9 12525873 1:CAS:528:DC%2BD3sXhtFGmt70%3D
52. M Gotteland M Lopez C Munoz R Saez H Altshiller P Llorens 1999 Local and systemic liberation of proinflammatory cytokines in ulcerative colitis Dig Dis Sci 44:830-5 10219845 10.1023/A:1026690631693 1:STN:280:DyaK1M3jsFamsw%3D%3D